SEARCH RESULTS FOR: "Tag: ARRY"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(6)
2017(11)
2016(5)
2015(4)
CATEGORIES
Analyst Update(4)
Analyst Upgrades(1)
Buzz Stocks(7)
By the Numbers(1)
Earnings Preview(1)
General(1)
Intraday Option Activity(4)
Midday Market Check(2)
Opening View(4)
Quantitative Analysis(1)
Stock Market News(2)
Stocks On the Move(6)
Technical Analysis(4)

5/21/2019 3:24 PM
U.S. markets are moving higher today, tech recovering from yesterday's sell-off. Three pharmaceutical names also making notable moves this afternoon are Array Biopharma Inc (NASDAQ:ARRY), Sesen Bio...
1/15/2019 1:42 PM
Cantor Fitzgerald today initiated coverage on Array Biopharma Inc (NASDAQ:ARRY) with an "overweight" rating and $30 price target -- representing a premium of 76% to Monday's close at $17.07. The brok...
1/7/2019 2:34 PM
Stocks are confidently higher today, powered by fresh U.S-China trade optimism. Drug stocks are in particular focus, as the J.P. Morgan Healthcare conference kicks off. Insmed Incorporated (NASDAQ:IN...
10/9/2018 2:26 PM
Last Friday, Array Biopharma Inc (NASDAQ:ARRY) gapped lower for its worst day since July 27, but there is a silver lining. That is, the pullback puts ARRY near a historically bullish trendline and ke...
8/7/2018 9:17 AM
Boulder-based Array Biopharma Inc (NASDAQ:ARRY) is attracting pre-market attention this morning, after its BRAFTOVI drug, in combination with MEKTOVI and cetuximab, was given a Breakthrough Therapy D...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center